Lipid-laden macrophage infiltration of human adenocarcinoma in vivo associated with taxol and GCSF treatment

Cancer Investigation

Volumn 15, Issue 1, 1997, Pages 18-22

  Abramson, Neil ^a   Castro, Salvador ^a   Goldstein, Jeffrey D ^a  

^a Baptist Regional Cancer Institute   (United States)

Author keywords

adenocarcinoma; chemotherapy; GCSF; macrophage; taxol

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; LIPID; PACLITAXEL;

ADULT; ARTICLE; CASE REPORT; CYTOLOGY; HUMAN; LUNG ADENOCARCINOMA; MACROPHAGE; MALE; PRIORITY JOURNAL;

EID: 0031015785     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.3109/07357909709018913     Document Type: Article

References (13)

1. Ding AH, Porteu F, Sanchez E, Nathan CF: Shared actions of endotoxin and taxol on TNF receptors and TNF release. Science 248:370-372, 1990.
2. Ding A, Sanchez E, Nathan CF: Taxol shares the ability of bacterial lipopolysaccharide to induce tyrosine phosphorylation of microtubule-associated protein kinase. J Immunol 151:5596-5602, 1993.
3. Ding A, Sanchez E, Tancinco M, Nathan C: Interactions of bacterial lipopolysaccharide with microtubule proteins. J Immunol 148: 2853-2858, 1992.
4. Manthey CL, Perera PY, Salkowski CA, Vogel SN: Taxol provides a second signal for murine macrophage tumoricidal activity. J Immunol 152:825-831, 1994.
5. Manthey CL, Brandes ME, Perera PY, Vogel SN: Taxol increases steady-state levels of lipopolysaccharide-inducible genes and protein-tyrosine phosphorylation in murine macrophages. J Immunol 149:2459-2465, 1992.
6. Rowinsky EK, Cazenave LA, Donehower RC: Taxol: A novel investigational antimicrotubule agent. J Natl Cancer Inst 82:1247-1259, 1990.
7. Williams S, Mutch DG, Xu L, Collins JL: Divergent effects of taxol on tumor necrosis factor-alpha-mediated cytolysis of ovarian carcinoma cells. Am J Obstet Gynecol 167:1870-1876, 1992.
8. Pugh-Humphreys RG: Macrophage-neoplastic cell interactions: Implications for neoplastic cell growth. FEMS Microbiol Immunol 5:289-308, 1992.
9. Dorsch M, Hock H, Kunzendorf U, Diamantstein T, Blankenstein T: Macrophage colony-stimulating factor gene transfer into tumor cells induces macrophage infiltration but not tumor suppression. Eur J Immunol 23:186-190, 1993.
10. Lieschke GJ, Grail D, Hodgson G, et al: Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization. Blood 84:1737-1746, 1994.
11. Wright DG, Kenney RF, Oette DH, La Russa VF, Boxer LA, Malech HL: Contrasting effects of recombinant human granulocyte-macrophage colony-stimulating factor (CFS) and granulocyte CSF treatment on the cycling of blood elements in childhood-onset cyclic neutropenia. Blood 84:1257-1267, 1994.
12. Lord BI, Molineux G, Pojda Z, Souza LM, Mermod JJ, Dexter TM: Myeloid cell kinetics in mice treated with recombinant interleukin-3, granulocyte colony-stimulating factor (CSF), or granulocyte-macrophage CSF in vivo. Blood 77:2154-2159, 1991.
13. Liu KY, Akashi K, Harada M, Takamatsu Y, Niho Y: Kinetics of circulating haematopoietic progenitors during chemotherapy-induced mobilization with or without granulocyte colony-stimulating factor. Br J Haematol 84:31-38, 1993.